RICHMOND HILL, ON – Qvella has raised a Series A round of financing. The Toronto-based (Richmond Hill) molecular diagnostics company raised US$20 million.
The round was co-led by RA Capital Management and Whitecap Venture Partners, and includes Hatteras Venture Partners and Sands Capital Ventures as syndicate partners, Qvella says.
Full Article Here: www.techvibes.com
The post Richmond Hill Based Qvella Raises $26 Million Series A Round to Revolutionize Pathogen Detection appeared first on Toronto Area's Tech Hub.